Felix R Dulanto, MD | |
7625 Old Springville Rd, Trussville, AL 35173-1739 | |
(205) 879-8294 | |
(205) 879-8259 |
Full Name | Felix R Dulanto |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 7625 Old Springville Rd, Trussville, Alabama |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1043479124 | NPI | - | NPPES |
131837 | Medicaid | AL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208M00000X | Hospitalist | 29733 (Alabama) | Primary |
Mailing Address | Practice Location Address |
---|---|
Felix R Dulanto, MD Po Box 530604, Birmingham, AL 35253-0604 Ph: (205) 879-8294 | Felix R Dulanto, MD 7625 Old Springville Rd, Trussville, AL 35173-1739 Ph: (205) 879-8294 |
News Archive
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, recently announced its management team was flying to China to close its merger with Zhuhai Energy Science and Technology. Biomagnetics Diagnostics is pleased today to announce the signing of the formal merger agreement. All necessary governmental approvals are expected to be completed mid-week.
A third of Americans with diabetes do not know that they have it, and many more who have prediabetic conditions are unaware that they are at risk.
How can six and half feet of DNA be folded into the tiny nucleus of a cell? Researchers funded by the National Institutes of Health have developed a new imaging method that visualizes a very different DNA structure, featuring small folds of DNA in close proximity.
New research presented at the annual meeting of the European Association for the Study of Diabetes and published simultaneously in The Lancet Diabetes & Endocrinology shows how the glucose-lowering drug lixisenatide can slow or prevent damage to the kidneys in macro-albuminuric patients with type 2 diabetes mellitus and cardiovascular disease.
› Verified 5 days ago